Abstract
The incidence of suicide in adolescents has been increasing, making it more and more important to arrive at an accurate diagnosis and to mount effective prevention programs.1 Efforts to construct a behavior profile that predicts risk of attempted or completed suicide have been unsuccessful. Only weak correlations exist at present between suicide and types of premorbid behavior. Current profiles of the child at suicide risk turn up many false-positive results,2 suggesting that available models have low specificity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Curran DK: Adolescent Suicidal Behavior. Hagerstown, Maryland, Harper & Row, 1987, pp 14
Cohen J: Statistical approaches to suicidal risk factor analysis, in Stanley M Mann JJ (eds), Psychobiology of Suicidal behavior. New York, New York Academy of Sciences, 1986, pp 34–41
Lloyd KG, Farley IJ, Deck JHN, et al : Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients, in Advances in Biochemical Psychopharmacology, Vol. II. New York, Raven Press, 1974, pp 387–397
Pare CMB, Yeung DPH, Price K, et al : 5-Hydroxytryptamine, noradrenaline and dopamine in brain steam, hypothalamus and caudate nucleus of controls of patients committing suicide by coal-gas poising. Lancet 1:131–135, 1969
Shaw DM, Camps FE, Eccleston EG : 5-hydroxytryptamine in the hind brain of depressive suicides. Br J Psychiatry 113:1407–1411, 1967
Korpi ER, Kleinman JE, Goodman SI, et al : Serotonin and 5-hydroxyindolacetic acid concentrations in different brain regions of suicide victims: Comparison in chronic schizophrenic patients with suicide as cause of death. Presented at theInternational Society of Neurochemistry, Vancouver, Canada 1983
Gillin JC, Kelsoe JR, Kaufman CA, et al : Muscarinic receptor density in skin fibroblasts and autopsied brain tissue in affective disorder. Presented atPsychobiology of Suicide Behavior. New York, New York Academy of Sciences, September 1985, pp 143–147
Bourne HR, Bunney WE Jr, Colburn RW, et al: Noradrenaline, 5-hydroxytryptamine, and 5-indoleacetic acid in the human brain: Post mortem studies in a group of suicides and in a control group. Lancet 2:805–808, 1968
Beskow J, Gottfriess GC, Roos BE, et al : Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group. Acta Psychiatr Scand 53:7–20, 1976
Stanley M, Mann JJ : Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 2:214–216, 1983
Crow TJ, Cross AJ, Cooper SJ, et al : Neurotransmitter receptors and monoamine metabolites in the patient with Alzheimer-type dementia and depression and suicides. Neuropharmacology 23:1561–1569, 1984
Owen F, Cross AJ, Crow TJ, et al : Brain 5-HT2 receptors and suicide. Lancet 2:1256, 1963
Grote SS, Moses SG, Robins, E, et al : A study of selected catecholamine metabolizing enzymes: A comparison of depressive suicides and alcoholic suicides with controls. J Neurochem 23:791–236, 1974
Gottfries, CG, Knorring LV, Oreland L : Platelet monamine oxidase activity in brains from alcoholic. J Neurochem, 25:667–673, 1975
Mann JJ, Stanley M : Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls. Acta Psychiatr Scand 69:135–139, 1984
Langer SZ, Moret C, Raisman R, et al ; High-affinity [3H]imipramine binding in rat hypothalamus: Association with uptake of serotonin but not of norepinephrine. Science 210:1133–1135, 1980
Brunello N, Chuang DM, Costa E : Different synaptic location of mianserin and imipramine binding sites. Science 215:1112–1115, 1982
Rehavi M, Skolnick P, Paul SM : Solubilization and partial purification of the high affinity [3H]imipramine binding site from human platelets. FEBS Lett 150:514–518, 1982
Raisman R, Sechter D, Briley MS, et al : High affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers. Psychopharmacology 75:368–371, 1981
Stanley M, Virgilio J, Gershon S : Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1337–1339, 1982
Paul SM, Rehavi M, Skolnick P, et al : High affinity binding of antidepressants to a biogenic amine transport site in human brain and platelet: Studies in depression, in Post RM Ballenger JC(eds), Neurobiology and Mood Disorders. Baltimore, William & Wilkins, 1984, pp 846–853
Meyerson LR, Wennogle LP, Abel MS, et al : Human brain receptor alterations in suicide victims. Pharmacol Biochem Behav 17:159–163, 1982
Peroutka SJ, Snyder SH : Regulation of serotonin (5-HT2) labeled with [3H] spiroperidol by chronic treatment with antidepressant amitriptyline. Pharmacol Exp Therap 215:582–587, 1980
Mann JJ, Stanley M, McBride AP, et al : Increased serotonin and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954–959, 1986
Meltzer HY, Nash JF, Ohmori T, et al : Neuroendocrine and biochemical studies of serotonin and dopamine in depression and suicide. International Conference on New Directions in Affective Disorders, S60, 1987
Cheetham SC, Crompton MR, Katona CLE, Horton RW : Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res. 443:272–280, 1988
Janowsky DS, El-Yousef MK, David JM, et al : A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1:632, 1972
Stanley M : Cholinergic receptor binding in the frontal cortex of suicide victims. Am J Psychiatry 141:1432–1436, 1984
Kaufman CA, Gillin JC, Hill B, et al : Muscarinic binding sites in suicides. Psychiatry Res 12:47–55, 1984
Sulser F, Robonson SE : Clinical implications of pharmacological differences among antipsychotic drugs, In Lipton MA DiMascio A Killam KF(eds), Psychopharmacology: A Generation of Progress. New York, Raven, 1978, pp 943–954
Zanko MT, Biegon A : Increased p-adrenergic receptor binding in human frontal cortex of suicide victims. Abstract of theAnnual Meeting, Society of Neuroscience, Boston, 1983
Biegon A : Findings in beta receptors in suicide victims. Grand Rounds, Rockefeller University, June 1987
Nemeroflf CB, Widerlow E, Bissett G, et al: Arch Gen Psychiatry, 45:577–579, 1988
Ashby P, Verrier M, Wash JJ, et al : Spinal reflexes and the concentrations of 5-HIAA, MHPG and HVA in lumbar cerebrospinal fluid after spinal lesions in man. J Neurol Neurosurg Psychiatry 39:1191–1200, 1976
Curzon G, Gumpert EJ, Sharpe DM : Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid. Nature New Biol 231:189–191, 1971
Post RM, Goodwin FK, Gordon E, et al : Amine metabolites in human cerebrospinal fluid: Effects of cord transection and spinal fluid block. Science 179:897–899, 1973
Stanley M, Traskman-Bendz L, Dorovini-Zis K : Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 37:1279–1286, 1985
Asberg M, Thoren P, Traskman L, et al: Serotonin depression: A biochemical subgroup within the affective disorders? Science 191:478–480, 1976
Asberg M, Traskman L, Birtilson L, et al : Studies of CSF 5-HIAA in depression and suicidal behavior. Exp Med Biol 133:739–752, 1981
Agren H : Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid. II. Suicide Psychiatry Res 3:225–236, 1980
Van Praag HM : Depression, suicide and the metabolism of serotonin in the brain. J Affective Dis 4:275–290, 1982
Banki CM, Arato M, Papp Z, et al : Biochemical markers in suicidal patients: Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affective Dis 6:341–350, 1984
Palanappian V, Ramachandran V, Somasundaram O : Suicidal ideation and biogenic amines in depression. Indian J Psychiatry 25:268–292, 1983
Montgomery SA, Montgomery D : Pharmacological prevention of suicidal behavior. J Affective Dis 4:291–298, 1982
Perez de los Cobos JZ, Lopez-Ibor Alino JJ, Saiz Ruiz J : Correlatos biologicaos del suicido y la agresivivad en depressiones mayores (con melancholia): 5-HIAA en LCR, DST, y respuesta terapeutica a 5-HTP. Presented at the First Congress of the Spanish Society for Biological Psychiatry, Barcelona, 1984
Brown GL, Goodwin FK, Ballenger JC, et al : Aggression in humans correlates with cerebrospinal fluid amine metabolism. Psychiatry Res 1:131–139, 1979
Brown GL, Ebert MH, Goyer PF, et al : Aggression, suicide and serotonin; relationships to CSF amine metabolites. Am J Psychiatry 139:741–746, 1982
Traskman L, Asberg M, Bertillsson K, et al : Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631–636, 1981
Linnoila M, Virkkunen M, Scheinin M, et al : Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations differentiates impulsive violent behavior. Life Sci 33:2609–2614, 1983
Van Praag HM : CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet 2:977–978, 1984
Ninan PT, Van Kammen DP, Scheinin M, et al : CSF 5-hydroxyindoleacetic acid in suicidal schizophrenic patients. Am J Psychiatry 141:566–569, 1984
Miles CL : Conditions predisposing to suicide. J Nerv Ment Dis 164:231–246, 1977
Tsuang MT : Suicide in schizophrenics, manics, depressives, and surgical controls. Arch Gen Psychiatry 35:153–155, 1978
Roy A : Suicide in chronic schizophrenics. Br J Psychiatry 144:171–177, 1982
Roy A, Ninam P, Mazonson A, et al : CSF monoamine metabolite in chronic schizophrenia patients who attempt suicide. Psychol Med 15:335–340, 1985
Pickar D, Roy A, Brier A, et al : Suicide and aggression in schizophrenia: neurobiologic correlates, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 189–196
Jamison KR : Suicide and bipolar disorders, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 301–315
Roy-Byme P, Post RM, Rubinow DR, et al : CSF 5-HIAA and personal and family history of suicide in affectively ill patients: a negative study. Psychiatry Res 10:263–274, 1983
Berrettini W, Nurenberger J, Narrow W, et al : Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts, in Mann JJ Stanley M(eds): Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 197–201
Goodwin FK : Suicide aggression and depression: A theoretical framework for future research, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 351–356
Banki C, Arato M, Kilts C : Aminergic studies and cerebrospinal fluid cautions in suicide, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 221–230
Banki C : Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. J Neural Transm 50:98–101, 1981
Ballenger JC, Goodwin FK, Major LF, et al : Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 36:224–227, 1979
Tabakoff B, Ritzmann R : Inhibition of the transport of 5-hydroxyindoleacetic acid from brain by ethanol. J Neurochem 24:1043–1051, 1975
Ellingboe J : Effect of alcohol on neurochemical processes, in Lipton M DiMascio A Killman K(eds), Psychopharmacology: A Generation of Progress. New York, Raven, 1978, pp 1653–1654
Herrero E : Monoamine metabolism in rat brain regions following long-term alcohol treatment. J Neural Transm 47:227–236, 1980
Secunda JA, Cross CK, Koslow K, et al : Biochemistry and suicidal behavior in depressed patients. Biol Psychiatry 21:756–767, 1986
Oreland L, Wilberg A, Asberg M, et al : Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Res 4:21–29, 1981
Arato M, Banki CM, Nemeroff CB, et al : Hypothalamic-pituitary-adrenal axis and suicide, in Mann JJ Stanley M, (eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 263–270
Stoff D, Pollack L, Bridger WL : Platelet imipramine binding sites correlate with aggression in adolescents. Biol Psychiatry 12:180–182, 1986
Shaffer D, Bacon K : A critical review of prevention intervention efforts in suicide with particular preference to youth suicide. Prepared for thePrevention and Intervention Work Group of HHS Task Force on Youth Suicide. Presented inOakland, California, June 11–13, 1986
Grottfries CG, Knorring LV, Oreland L : Platelet monamine oxidase activity in mental disorders. Neuropsychopharmacology 4:185–192, 1980
Buchsbaum MS, Hairr RJ, Murphy DL : Suicide attempts, platelet monoamine oxidase and the average evoked response. Acta Psychiatry Scand 56:69–77, 1979
Meltzer HY, Arora RC : Platelet markers of suicidality, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 271–280
Bunney WE Jr, Fawcett JA, Davis JM, et al: Possibility of a biochemical test for suicidal potential. Arch Gen Psychiatry 13:232–239, 1965
Bunney WE Jr, Fawcett JA, Davis JM, et al: Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. Arch Gen Psychiatry 21:138–150, 1969
Ostroff R, Giller E, Bonese K, et al : Neuroendocrine risk factors of suicide. Am J Psychiatry 139:1323–1325, 1982
Levy B, Hensen E : Failure of the urinary test for suicidal potential. Arch Gen Psychiatry 20:415–418, 1969
Carroll BJ, Greden JF, Feinberg M : Suicide, neuroendocrine dysfunction and CSF 5-HIAA concentrations in depression, in Angrist B (ed), Recent Advances in Neuropsychopharmacology. Oxford, Pergamon, 1981, pp 307–313
Kocsis JH, Kennedy S, Brown RP, et al : Neuroendocrine studies in depression: Relationship to suicidal behavior, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior. New York, New York Academy of Sciences, 1986, pp 256–262
Targum SD, Rosen L, Capodanno AE : The dexamethasone suppression test in suicidal patients with unipolar depression. Am J Psychiatry 140:877–879, 1983
Banki CM, Aroto M : Amine metabolites and neuroendocrine responses related to depression and suicide. J Affective Disord 5:223–232, 1983
Van Waltere JP, Charles G, Wilmotte J : Tests de function a la dexamethasome et suicide. Acta Psychiatr Scand 83:569–578, 1983
Meltzer HY, Perline R, Tricou BJ, et al : Affect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis and depressive symptoms. Arch Gen Psychiatry 41:379–387, 1984
Cocarro EF, Siever LJ, Klar H, et al : Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 46:587–599, 1989
Stanley MM, Mann JJ : Biological factors associated with suicide, in Frances AJ and Hales RE, APA Review of Psychiatry, Vol. 7, 1987, pp 334–352
Valzelli L : Psychobiology of Aggression and Violence. New York, Raven, 1981
Cochran E, Robins E, Grote S : Regional serotonin levels in brain: A comparison of depressive suicides and alcoholic suicides with controls. Biol Psychiatry 11:283–295, 1976
Beskow J, Gottfries CG, Roos BE, et al : Determination of monoamine and monoamine metabolites in the human brain: Postmortem studies in a group of suicides and in a control group. Acta Psychiatr Scand 53:7–20, 1976
Bourse HR, Bunney WE Jr, Colburn RW, et al: Noradrenadine, 5-hydroxyindoleacetic acid of suicidal patients. Lancet ii:805–808, 1968
Korpi ER, Kleinman JE, Goodman SI, et al : Serotonin and 5-hydroxyindoleacetic acid concentrations in different brain regions of suicide victims: Comparison in chronic Schizophrenic patients with suicide as cause of death. Presented at theInternational Society for Neurochemistry, Vancouver, Canada, 1983
Crow TJ, Cross AJ, Cooper SJ, et al : Neurotransmitter receptors and monoamine metabolites in the patients with alzheimer-type dementia and depression and suicides. Neuropharmacology 23:1561–1569, 1984
Perry EK, Marshall EF, Blessed G, et al : Decreased imipramine binding in the brains of patients with depresseve illness. Br J Psychiatry 142:188–192, 1983
Owens F, Cross AJ, Crow TJ, et al : Brain 5-HT receptors and suicide. Lancet 2:1283, 1983
Zanko MT, Biegon A : Increased B-adrenergic receptor binding in human frontal cortex of suicide victims. Abstr. of theAnnual Meeting, Society of Neuroscience, Boston, 1983
Mann JJ, Stanley M, McBride AP, et al : Increased serotonin and beta-adrenergic receptor binding in the frontal orifices of suicide victims. Arch Gen Psychiatry 43:954–959, 1986
Traskman L, Asberg M, Bertilsson K, et al : Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631–636, 1987
Montgomery SA, Montgomery D : Pharmacological prevention of suicidal behavior. J Affective Disord 4:291–298, 1982
Palanappian V, Rauachandler V, Somosundaran O : Suicidal ideation and biogenic amines in depression. Indian J Psychiatry 25:268–292, 1983
Banki CM, Arato M, Papp Z, et al : Biochemical markers in suicidal patients: Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affective Disord 6:341–350, 1984
Perez de los Cobos JZ, Lopez-Ibor Alino JJ, Saiz Ruiz J : Correlatos biologicos del suicido y la agresividad en depressiones mayores (con melancolia): 5-HIAA en LCR, DST, y respuesto terapeutica a 5-HTp. Presented to the first Congress of the Spanish Society for Biological Psychiatry, Barcelona, 1984
Berrettini W, Nurenberger J, Narrow W, et al. : Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts, in Mann JJ Stanley M(eds), Psychobiology of Suicidal Behavior, New York, New York Academy of Sciences, 1986
Van Praag HM : CSF 5-HIAA and suicide in nondepressed schizophrenics. Lancet 2:977–978, 1983
Ninan PT, Van Kammen DP, Scheinin M, et al : CSF 5-hydroxyindoleacetic acid in suicidal schizophrenic patients. Am J Psychiatry 141:566–569, 1984
Stanley M, Stanley B, Traskman-Bendz L, Winchel R, and Jones JS : An assessment of the biochemical findings in schizophrenic patients who attempt suicide. Athens, Greece, VIII World Congress of Psychiatry, Abstract, 1989
Banki CM, Alato M : Amine metabolites and neuroendocrine responses related to depression and suicide. J. Affective Disord 5:225–232, 1983
Brown GL, Goodwin FK, Ballenger, JC, et al : Ag ression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1:131–139, 1979
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Publishing Corporation
About this chapter
Cite this chapter
Birmaher, B., Greenhill, L.L., Stanley, M. (1990). Biochemical Studies of Suicide. In: Deutsch, S.I., Weizman, A., Weizman, R. (eds) Application of Basic Neuroscience to Child Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0525-5_20
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0525-5_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7849-8
Online ISBN: 978-1-4613-0525-5
eBook Packages: Springer Book Archive